Primary Breast Sarcoma: A Two-Centre Analysis and Review of Literature
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
37900556
PubMed Central
PMC10601702
DOI
10.1159/000530934
PII: 530934
Knihovny.cz E-zdroje
- Klíčová slova
- Primary breast sarcoma, Prognostic factors, Two-centre analysis,
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Primary breast sarcoma is a very rare malignant type of breast tumours with an incidence of 0.1% of all primary breast malignancies. METHODS: We present a retrospective analysis of the case series from two hospitals in the Czech Republic with a review of the diagnostic and treatment approach to primary breast sarcomas with an analysis of published prognostic factors. RESULTS: Eleven patients were included in the study, 9 women and 2 men. Statistical evaluation revealed that tumour size (p = 0.1964), grade (p = 0.1667), margin distance (p = 0.5403), mitotic activity (p = 0.8577), or age (p = 0.7822) were not prognostic factors in our cohort. CONCLUSION: The analysis did not prove any of the factors, such as age, tumour size, grade, or mitotic activity, to be statistically significant prognostic factors. Based on the literature review, the most common published prognostic factors are tumour size, margin status, and grade, but the results are ambiguous.
Department of Comprehensive Cancer Care Faculty of Medicine Masaryk University Brno Czech Republic
Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Pathology Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Pathology Silesian Hospital in Opava Opava Czech Republic
Department of Radiation Oncology Faculty of Medicine Masaryk University Brno Czech Republic
Department of Radiation Oncology Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Surgery Silesian Hospital in Opava Opava Czech Republic
Department of Surgical Oncology Faculty of Medicine Masaryk University Brno Czech Republic
Department of Surgical Oncology Masaryk Memorial Cancer Institute Brno Czech Republic
Zobrazit více v PubMed
Adem C, Reynolds C, Ingle J, Nascimento A. Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature. Br J Cancer. 2004;91(2):237–41. 10.1038/sj.bjc.6601920. PubMed DOI PMC
Mergancová J, Lierová A, Coufal O, Žatecký J, Melichar B, Zedníková I, et al. . Radiation-associated angiosarcoma of the breast: an international multicenter analysis. Surg Oncol. 2022;41:101726. 10.1016/j.suronc.2022.101726. PubMed DOI
National Comprehensive Cancer Network . NCCN Guidelines for Soft Tissue Sarcoma. National Comprehensive Cancer Network; 2022. [cited 2022-04-23]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf.
Wang L, Lao I, Yu L, Yang W, Wang J. Primary breast angiosarcoma: a retrospective study of 36 cases from a single Chinese medical Institute with clinicopathologic and radiologic correlations. Breast J. 2017;23(3):282–91. 10.1111/tbj.12731. PubMed DOI
Pandey M, Mathew A, Abraham E, Rajan B. Primary sarcoma of the breast. J Surg Oncol. 2004;87(3):121–5. 10.1002/jso.20110. PubMed DOI
Gutman H, Pollock R, Ross M, Benjamin R, Johnston D, Janjan N, et al. . Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience. Surgery. 1994;116(3):505–9. PubMed
Confavreux C, Lurkin A, Mitton N, Blondet R, Saba C, Ranchère D, et al. . Sarcomas and malignant phyllodes tumours of the breast: a retrospective study. Eur J Cancer. 2006;42(16):2715–21. 10.1016/j.ejca.2006.05.040. PubMed DOI
Barrow B, Janjan N, Gutman H, Benjamin R, Allen P, Romsdahl M, et al. . Role of radiotherapy in sarcoma of the breast: a retrospective review of the M.D. Anderson experience. Radiother Oncol. 1999;52(2):173–8. 10.1016/s0167-8140(99)00070-5. PubMed DOI
Ahuja M, Mallya V, Mandal S, Tomar R, Aggarwal R, Khurana N, et al. . Primary breast sarcoma: a case series. Indian J Pathol Microbiol. 2022;65(1):152–6. 10.4103/IJPM.IJPM_1315_20. PubMed DOI
Brierley J, Gospodarowicz M, Wittekind C. TNM classification of malignant tumours. 8th ed. UICC: Wiley-Blackwell; 2016.
Al-Benna S, Poggemann K, Steinau H, Steinstraesser L. Diagnosis and management of primary breast sarcoma. Breast Cancer Res Treat. 2010;122(3):619–26. 10.1007/s10549-010-0915-y. PubMed DOI
Pencavel T, Hayes A. Breast sarcoma: a review of diagnosis and management. Int J Surg. 2009;7(1):20–3. 10.1016/j.ijsu.2008.12.005. PubMed DOI
Ciatto S, Bonardi R, Cataliotti L, Cardona G. Sarcomas of the breast: a multicenter series of 70 cases. Neoplasma. 1992;39(6):375–9. PubMed
Gutnik L, Ren Y, Thomas S, Plichta J, Greenup R, Fayanju O, et al. . Malignant phyllodes tumor and primary breast sarcoma; distinct rare tumors of the breast. J Surg Oncol. 2022;125(6):947–57. 10.1002/jso.26820. PubMed DOI PMC
Ragavan S, Lim H, Tan J, Hendrikson J, Chan J, Farid M, et al. . Axillary lymph node dissection in angiosarcomas of the breast: an asian institutional perspective. Sarcoma. 2020;2020:4890803. 10.1155/2020/4890803. PubMed DOI PMC
Esses K, Hagmaier R, Blanchard S, Lazarchick J, Riker A. Carcinosarcoma of the breast: two case reports and review of the literature. Cases J. 2009;2(1):15. 10.1186/1757-1626-2-15. PubMed DOI PMC
Brito J, Gatti G, Vento A, Galimberti V, Intra M, Sahium De Almeida R, et al. . Report on a case of breast sarcoma metastatic to the axillary lymph nodes. Tumori. 2006;92(2):188–90. 10.1177/030089160609200219. PubMed DOI
McGowan T, Cummings B, O’Sullivan B, Catton C, Miller N, Panzarella T. An analysis of 78 breast sarcoma patients without distant metastases at presentation. Int J Radiat Oncol Biol Phys. 2000;46(2):383–90. 10.1016/s0360-3016(99)00444-7. PubMed DOI
Lee J, Yoon K, Onyshchenko M. Sarcoma of the breast: clinical characteristics and outcomes of 991 patients from the national cancer database. Sarcoma. 2021;2021:8828158. 10.1155/2021/8828158. PubMed DOI PMC
Osman M, Rabie N, Elmehrath A, Bedair H, Fala S, Ghaith H, et al. . Primary and secondary breast sarcoma: clinical and pathological characteristics, prognostic factors, and nomograms for predicting survival. Clin Breast Cancer. 2022;22(7):e753–63. 10.1016/j.clbc.2022.07.006. PubMed DOI
Al-Wiswasy M, Al-Balas M, Al-Saffar R, Al-Balas H. Primary stromal sarcoma of breast: a case report and literature review. Breast Dis. 2021;40(3):199–205. 10.3233/BD-201012. PubMed DOI
Bousquet G, Confavreux C, Magné N, de Lara C, Poortmans P, Senkus E, et al. . Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network. Radiother Oncol. 2007;85(3):355–61. 10.1016/j.radonc.2007.10.015. PubMed DOI
Lum Y, Jacobs L. Primary breast sarcoma. Surg Clin North Am. 2008;88(3):559–70, vi. 10.1016/j.suc.2008.03.009. PubMed DOI
Zelek L, Llombart-Cussac A, Terrier P, Pivot X, Guinebretiere J, Le Pechoux C, et al. . Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up. J Clin Oncol. 2003;21(13):2583–8. 10.1200/JCO.2003.06.080. PubMed DOI
Miyazaki C, Shiozawa M, Koike R, Ogihara K, Sasaki Y, Shiba S, et al. . Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report. J Med Case Rep. 2019;13(1):289. 10.1186/s13256-019-2197-2. PubMed DOI PMC
Luczynska E, Rudnicki W, Kargol J, Szpor J, Hodorowicz-Zaniewska D, Wysocki P, et al. . Primary bilateral angiosarcoma of the breast treated with neoadjuvant chemotherapy combined with propranolol. Breast J. 2021;27(10):781–6. 10.1111/tbj.14272. PubMed DOI
Fields R, Aft R, Gillanders W, Eberlein T, Margenthaler J. Treatment and outcomes of patients with primary breast sarcoma. Am J Surg. 2008;196(4):559–61. 10.1016/j.amjsurg.2008.06.010. PubMed DOI
Norris H, Taylor H. Sarcomas and related mesenchymal tumors of the breast. Cancer. 1968;22(1):22–8. 10.1002/1097-0142(196807)22:1<22::aid-cncr2820220105>3.0.co;2-r. PubMed DOI
Oberman H. Sarcomas of the breast. Cancer. 1965;18(10):1233–43. 10.1002/1097-0142(196510)18:10<1233::aid-cncr2820181004>3.0.co;2-m. PubMed DOI
North J Jr, McPhee M, Arredondo M, Edge S. Sarcoma of the breast: implications of the extent of local therapy. Am Surg. 1998;64(11):1059–61. PubMed
Barnes L, Pietruszka M. Sarcomas of the breast. A clinicopathologic analysis of ten cases. Cancer. 1977;40(4):1577–85. 10.1002/1097-0142(197710)40:4<1577::aid-cncr2820400430>3.0.co;2-d. PubMed DOI
Terrier P, Terrier-Lacombe M, Mouriesse H, Friedman S, Spielmann M, Contesso G. Primary breast sarcoma: a review of 33 cases with immunohistochemistry and prognostic factors. Breast Cancer Res Treat. 1989;13(1):39–48. 10.1007/BF01806549. PubMed DOI
Rosen P, Kimmel M, Ernsberger D. Mammary angiosarcoma: the prognostic significance of tumor differentiation. Cancer. 1988;62(10):2145–51. 10.1002/1097-0142(19881115)62:10<2145::aid-cncr2820621014>3.0.co;2-o. PubMed DOI
Nascimento A, Raut C, Fletcher C. Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. Am J Surg Pathol. 2008;32(12):1896–904. 10.1097/PAS.0b013e318176dbc7. PubMed DOI
Wang F, Jia Y, Tong Z. Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor. Jpn J Clin Oncol. 2015 Jan;45(2):146–52. 10.1093/jjco/hyu177. PubMed DOI
Qiu SQ, Wei XL, Huang WH, Wu MY, Qin YS, Li YK, et al. . Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013 Dec;3(1):2529. 10.1038/srep02529. PubMed DOI PMC
Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, et al. . Angiosarcoma of the breast. Cancer. 2005 Dec;104(12):2682–8. 10.1002/cncr.21531. PubMed DOI
Pollard SG, Marks PV, Temple LN, Thompson HH. Breast sarcoma. A clinicopathologic review of 25 cases. Cancer. 1990;66(5):941–4. 10.1002/1097-0142(19900901)66:5<941::aid-cncr2820660522>3.0.co;2-b. PubMed DOI
Christensen L, Schiødt T, Blichert-Toft M, Hansen JP, Hansen OH. Sarcomas of the breast: a clinico-pathological study of 67 patients with long term follow-up. Eur J Surg Oncol. 1988;14(3):241–7. PubMed
Berg JW, Decrosse JJ, Fracchia AA, Farrow J. Stromal sarcomas of the breast. A unified approach to connective tissue sarcomas other than cystosarcoma phyllodes. Cancer. 1962;15:418–24. 10.1002/1097-0142(196203/04)15:2<418::aid-cncr2820150226>3.0.co;2-v. PubMed DOI
Fujita N, Kimura R, Yamamura J, Akazawa K, Kasugai T, Tsukamoto F. Leiomyosarcoma of the breast: a case report and review of the literature about therapeutic management. Breast. 2011;20(5):389–93. 10.1016/j.breast.2011.03.001. PubMed DOI
Gutkin P, Ganjoo K, Lohman M, von Eyben R, Charville G, Nazerali R, et al. . Angiosarcoma of the breast: management and outcomes. Am J Clin Oncol. 2020;43(11):820–5. 10.1097/COC.0000000000000753. PubMed DOI
Abdou Y, Elkhanany A, Attwood K, Ji W, Takabe K, Opyrchal M. Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast Cancer Res Treat. 2019;178(3):523–33. 10.1007/s10549-019-05432-4. PubMed DOI PMC